<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2183-8453</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Saúde Ocupacional online]]></journal-title>
<abbrev-journal-title><![CDATA[RPSO]]></abbrev-journal-title>
<issn>2183-8453</issn>
<publisher>
<publisher-name><![CDATA[Ajeogene Serviços Médicos Lda]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2183-84532021000100057</article-id>
<article-id pub-id-type="doi">10.31252/rpso.29.05.2021</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[DERMATITE DE CONTACTO ALÉRGICA A ISOTIAZOLINONAS EM TÉCNICO DE MANUTENÇÃO ELÉTRICA INDUSTRIAL- CASO CLÍNICO]]></article-title>
<article-title xml:lang="en"><![CDATA[ALLERGIC CONTACT DERMATITIS DUE TO ISOTIAZOLINONES IN AN INDUSTRIAL ELECTRICAL MAINTENANCE TECHNICIAN- CASE REPORT]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mota]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Caldas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pardal]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Português de Oncologia de Lisboa Francisco Gentil  ]]></institution>
<addr-line><![CDATA[Lisboa ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital de Braga  ]]></institution>
<addr-line><![CDATA[Braga ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital de Braga  ]]></institution>
<addr-line><![CDATA[Braga ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Instituto Português de Oncologia de Lisboa Francisco Gentil  ]]></institution>
<addr-line><![CDATA[Lisboa ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>06</month>
<year>2021</year>
</pub-date>
<volume>11</volume>
<fpage>57</fpage>
<lpage>64</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2183-84532021000100057&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2183-84532021000100057&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2183-84532021000100057&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução: As isotiazolinonas são substâncias amplamente utilizadas como conservantes (biocidas) em produtos industriais, domésticos e cosméticos. São conhecidas há mais de quarenta anos como alergénios prevalentes causadores de dermatite de contacto em contexto profissional e extraprofissional. Relata-se um caso de dermatite de contacto alérgica profissional não exclusiva.  Caso Clínico: Homem de 47 anos de idade, técnico de manutenção elétrica industrial desde há 28 anos, referenciado à consulta de Alergologia Cutânea do Serviço de Dermatologia do Hospital de Braga, por lesões crónicas em placas, eritematosas e pruriginosas, localizadas no dorso e dedos das mãos, com agravamento durante a atividade profissional. Foi relatada pelo trabalhador uma melhoria clínica com o afastamento do local de trabalho em períodos de descanso e férias, mas com agravamento mais recente após aplicação de produtos de uso pessoal e doméstico. Por suspeita de dermatite de contacto foram realizados testes epicutâneos, com a série padrão do Grupo Português de Estudos das Dermatites de Contacto e três séries complementares - bateria de cosméticos, óleos de corte e conservantes. A leitura dos testes efetuada às setenta e duas horas e revelou as seguintes reações positivas: metilIisotiazolinona (+++); Kathon CG® (+++) e octilisotiazolinona (+). No seguimento do trabalhador, obteve-se melhoria clínica com substituição de todos os produtos domésticos que possuem estes biocidas na sua composição. Por indicação do seu Médico do Trabalho, foi efetuada uma avaliação dos detergentes industriais, que confirmaram a presença de isotiazolinonas, tendo o empregador procedido à sua substituição.  Discussão/Conclusão: Com o aumento do número de casos desde os anos oitenta de dermatite de contacto causadas por isotiazolinonas, a sua legislação tem vindo a sofrer várias alterações. Contudo, estas substâncias continuam a ter um papel importante, particularmente a nível industrial, pela grande eficácia como conservantes. No caso deste trabalhador, a eliminação do uso de todos os produtos identificados com a presença das substâncias sensibilizadoras foi a medida implementada mais acessível e praticável, tanto a nível de produtos de uso pessoal e doméstico como de uso profissional. A nível da saúde ocupacional, quando esta medida não é possível, é necessário implementar outras que diminuam o risco para a saúde dos trabalhadores, tanto coletivas, como individuais, se as primeiras não forem suficientes. É ainda imprescindível manter uma vigilância contínua e adequada da Segurança e Saúde dos trabalhadores através de programas de prevenção de risco e promover a literacia sobre os fatores de risco a que estes estão expostos através de ações de formação e informação. A monitorização da tendência de dermatite de contacto alérgica a estas substâncias continua a ser relevante na atualidade.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: Isothiazolinones are substances widely used as preservatives and biocides in industrial, household and cosmetic products. They have been known for over 40 years as prevalent allergens that cause contact dermatitis in a professional and extra-professional context. This article reports a case of non-exclusive occupational allergic contact dermatitis.  Case report: A 47-year-old man, industrial electrical maintenance technician for 28 years, was referred to the Dermatology Department of Hospital de Braga, due to chronic erythematous, papular and titillating lesions on the back of the hands and fingers, worsening during professional activity. It was reported by the worker a clinical improvement during periods of rest and vacations and more recent aggravation with cosmetics products for personal and domestic use. Due to suspected contact dermatitis, epicutaneous tests were performed with the standard series of the Portuguese Group for the Study of Contact Dermatitis and also three complementary series- battery of cosmetics, cutting oils and preservatives. The reading was done at 72h and revealed the following positive reactions: methylIisothiazolinone (+++); Kathon CG&#8482; (+++) and octylisothiazolinone (+). In the follow-up of the worker, clinical improvement was obtained with the replacement of all household products and cosmetics that contained these biocides in their composition and after his occupational physician medical advice, an evaluation of industrial detergents was carried out, which confirmed the presence of isothiazolinones, that the employer promptly replaced.  Discussion/Conclusion: After an increase of cases since the 1980s of contact dermatitis caused by isothiazolinones, the legislation has undergone several changes. However, these substances continue to play an important role, particularly at an industrial level, due to the great effectiveness they have as preservatives and biocides. In the case of this worker, the elimination of the use of all products (personal and professional) identified in its composition with sensitizing substances was the most accessible and practicable implemented measure. In occupational health, when this measure is not possible, it is necessary to implement other measures that reduce the health risk of workers through protective collective and individual equipments. It is essential to keep a constant and adequate health screenings through risk prevention programs and also promote literacy on the risk factors to which they are exposed through training workshops and information actions. Monitoring the tendency of allergic contact dermatitis to these substances continues to be relevant today.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Isotiazolinonas]]></kwd>
<kwd lng="pt"><![CDATA[Metilisotiazolinona]]></kwd>
<kwd lng="pt"><![CDATA[Metilclorotiazolinona]]></kwd>
<kwd lng="pt"><![CDATA[Dermatite de Contacto Alérgica]]></kwd>
<kwd lng="pt"><![CDATA[Dermatose Ocupacional]]></kwd>
<kwd lng="pt"><![CDATA[Saúde Ocupacional]]></kwd>
<kwd lng="pt"><![CDATA[Medicina do Trabalho]]></kwd>
<kwd lng="pt"><![CDATA[Segurança no Trabalho]]></kwd>
<kwd lng="en"><![CDATA[Isothiazolinones]]></kwd>
<kwd lng="en"><![CDATA[Methylisothiazolinone]]></kwd>
<kwd lng="en"><![CDATA[Methylchlorothiazolinone]]></kwd>
<kwd lng="en"><![CDATA[Allergic Contact Dermatitis]]></kwd>
<kwd lng="en"><![CDATA[Occupational Dermatosis]]></kwd>
<kwd lng="en"><![CDATA[Occupational Medicine]]></kwd>
<kwd lng="en"><![CDATA[Occupational Safety]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosmaninho]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Moreira]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dermatite de contacto: revisão da literatura]]></article-title>
<source><![CDATA[Revista Portuguesa de Imunoalergologia]]></source>
<year>2016</year>
<volume>24</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>197-209</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>European Agency for Safety and Health at Work</collab>
<source><![CDATA[Skin Sensitisers]]></source>
<year>2003</year>
<publisher-name><![CDATA[FactsheetsN40]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nixon]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Frowen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Noyle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Occupational dermatoses]]></article-title>
<source><![CDATA[Australian Family Physician]]></source>
<year>2005</year>
<volume>34</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>327-33</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diepgen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ofenloch]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bruze]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bertuccio]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cazzaniga]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Coenraads]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of contact allergy in the general population in different European regions]]></article-title>
<source><![CDATA[British Journal of Dermatology]]></source>
<year>2016</year>
<volume>174</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>319-29</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aerts]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Montjoye]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Tromme]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Goossens]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Baeck]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Isothiazolinone derivatives and allergic contact dermatitis: a review and update]]></article-title>
<source><![CDATA[JEADV]]></source>
<year>2019</year>
<volume>33</volume>
<page-range>267-76</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bruze]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dahlquist]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Fregert]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gruvberger]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Persson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contact allergy to the active ingredients of Kathon CG]]></article-title>
<source><![CDATA[Contact Dermatitis]]></source>
<year>1987</year>
<volume>16</volume>
<page-range>183-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Belluco]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Giavina-Bianchi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dermatite de contato à metilisotiazolinona - estamos atentos a essa epidemia?]]></article-title>
<source><![CDATA[Arquivos de Asma, Alergologia e Imunologia]]></source>
<year>2019</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>139-42</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gameiro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Coutinho]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gonçalo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methylisothiazolinone: Second 'epidemic' of isothiazolinone sensitization]]></article-title>
<source><![CDATA[Contact dermatitis]]></source>
<year>2014</year>
<volume>70</volume>
<page-range>242-3</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Özkaya]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sayar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kobaner]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pehlivan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methylchloroisothiazolinone/ methylisothiazolinone and methylisothiazolinone contact allergy: a 24&#8208;year, single&#8208;center, retrospective cohort study from Turkey]]></article-title>
<source><![CDATA[Contact Dermatitis]]></source>
<year>2020</year>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>Jornal Oficial da União Europeia</collab>
<source><![CDATA[Regulamento (CE) nº 1223/2009 do Parlamento Europeu e do Conselho de 30 de novembro de 2009 relativo aos produtos cosméticos]]></source>
<year>2009</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>Jornal Oficial da União Europeia</collab>
<source><![CDATA[Regulamento (UE) nº 1003/2014 da Comissão de 18 de setembro de 2014 que altera o anexo V do Regulamento (CE) nº 1223/2009 do Parlamento Europeu e do Conselho relativo aos produtos cosméticos]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[English]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Occupational dermatoses: overview]]></article-title>
<source><![CDATA[Occupational Medicine]]></source>
<year>2004</year>
<volume>54</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>439-40</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uva]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Diagnóstico e Gestão do Risco em Saúde Ocupacional]]></source>
<year>2010</year>
<edition>2º</edition>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
